In patients with chronic granulomatous disease (CGD) who are deficient in NADPH oxidase-dependent phagocytosis, IFN-γ prophylaxis provides little protection against invasive filamentous fungal infections [14]. Here, FMO5 is linked to chronic granulomatous disease.